SE9704404D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9704404D0
SE9704404D0 SE9704404A SE9704404A SE9704404D0 SE 9704404 D0 SE9704404 D0 SE 9704404D0 SE 9704404 A SE9704404 A SE 9704404A SE 9704404 A SE9704404 A SE 9704404A SE 9704404 D0 SE9704404 D0 SE 9704404D0
Authority
SE
Sweden
Prior art keywords
new compounds
prevention
substituted
formula
treatment
Prior art date
Application number
SE9704404A
Other languages
English (en)
Swedish (sv)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9704404A priority Critical patent/SE9704404D0/xx
Publication of SE9704404D0 publication Critical patent/SE9704404D0/xx
Priority to ZA9810468A priority patent/ZA9810468B/xx
Priority to TW087118942A priority patent/TW515798B/zh
Priority to ARP980105799A priority patent/AR016972A1/es
Priority to MYPI98005216A priority patent/MY121032A/en
Priority to TR2000/01530T priority patent/TR200001530T2/xx
Priority to HU0100601A priority patent/HUP0100601A3/hu
Priority to CA002311798A priority patent/CA2311798A1/en
Priority to IDW20000987A priority patent/ID24730A/id
Priority to HK01101145.1A priority patent/HK1030216B/en
Priority to DK98957270T priority patent/DK1042324T3/da
Priority to ES98957270T priority patent/ES2191356T3/es
Priority to PT98957270T priority patent/PT1042324E/pt
Priority to NZ504355A priority patent/NZ504355A/en
Priority to UA2000052801A priority patent/UA70932C2/uk
Priority to SK674-2000A priority patent/SK283904B6/sk
Priority to JP2000523214A priority patent/JP2001525322A/ja
Priority to AT98957270T priority patent/ATE233263T1/de
Priority to PL98340920A priority patent/PL340920A1/xx
Priority to US09/194,823 priority patent/US6518270B1/en
Priority to EP98957270A priority patent/EP1042324B1/en
Priority to CNB98813344XA priority patent/CN1142933C/zh
Priority to RU2000113729/04A priority patent/RU2241000C2/ru
Priority to DE69811735T priority patent/DE69811735T2/de
Priority to AU13565/99A priority patent/AU752187C/en
Priority to KR1020007005804A priority patent/KR20010032559A/ko
Priority to BR9814755-2A priority patent/BR9814755A/pt
Priority to EEP200000315A priority patent/EE04060B1/xx
Priority to CZ20001947A priority patent/CZ292349B6/cs
Priority to SI9830381T priority patent/SI1042324T1/xx
Priority to IL13614598A priority patent/IL136145A0/xx
Priority to PCT/SE1998/002091 priority patent/WO1999028322A1/en
Priority to IS5486A priority patent/IS5486A/is
Priority to NO20002721A priority patent/NO315704B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9704404A 1997-11-28 1997-11-28 New compounds SE9704404D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds
ZA9810468A ZA9810468B (en) 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof
TW087118942A TW515798B (en) 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
ARP980105799A AR016972A1 (es) 1997-11-28 1998-11-16 Compuestos heterociclicos sustituidos con bencilo para la inhibicion de secrecion de acido gastrico, procesos para su preparacion, composicionesfarmaceuticas y uso de los mismos
MYPI98005216A MY121032A (en) 1997-11-28 1998-11-17 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
PCT/SE1998/002091 WO1999028322A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
JP2000523214A JP2001525322A (ja) 1997-11-28 1998-11-18 胃酸分泌を抑制する複素環式化合物、それらの製造法およびそれらの医薬組成物
EP98957270A EP1042324B1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
CA002311798A CA2311798A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
IDW20000987A ID24730A (id) 1997-11-28 1998-11-18 Senyawa-senyawa heterosiklik untuk penghambatan sekresi asam lambung, proses pembuatan dan komposisi-komposisi farmasinya
HK01101145.1A HK1030216B (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
DK98957270T DK1042324T3 (da) 1997-11-28 1998-11-18 Heterocykliske forbindelser til inhibering af mavesyresekretion, fremgangsmåder til deres fremstilling og farmaceutiske præparater deraf
ES98957270T ES2191356T3 (es) 1997-11-28 1998-11-18 Compuestos heterociclicos para la inhibicion de la secrecion de acidos gastricos, procedimientos para su preparacion y composiciones farmaceuticas de ellos.
PT98957270T PT1042324E (pt) 1997-11-28 1998-11-18 Compostos heterociclicos para inibicao da secrecaode acido gastrico processis para a sua prepara cao e suas composicoes farmaceuticas
NZ504355A NZ504355A (en) 1997-11-28 1998-11-18 Imidazopyrazine, pyrrolopyridazine, pyrrolopyridine, pyrrolopyrazine, imidazopyridazine or imidazopyrimidine derivatives substituted by benzoyloxy or benzylamino useful for inhibiting gastric acid secretions
UA2000052801A UA70932C2 (uk) 1997-11-28 1998-11-18 Гетероциклічні сполуки для пригнічення кислотності шлункового секрету, спосіб їх одержання (варіанти) та фармацевтична композиція, що їх містить (варіанти)
SK674-2000A SK283904B6 (sk) 1997-11-28 1998-11-18 Heterocyklické zlúčeniny na inhibíciu sekrécie žalúdočnej kyseliny, spôsoby ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
TR2000/01530T TR200001530T2 (tr) 1997-11-28 1998-11-18 Gastrik asit salgılamasının önlenmesi için heterosiklik bileşimler
AT98957270T ATE233263T1 (de) 1997-11-28 1998-11-18 Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
PL98340920A PL340920A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibiting gastric juice secretion, method of obtaining them and pharmacological agents containing such compounds
US09/194,823 US6518270B1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
HU0100601A HUP0100601A3 (en) 1997-11-28 1998-11-18 Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof
CNB98813344XA CN1142933C (zh) 1997-11-28 1998-11-18 抑制胃酸分泌的杂环化合物、其制备方法及其药物组合物
RU2000113729/04A RU2241000C2 (ru) 1997-11-28 1998-11-18 Гетероциклические соединения с замещенной фенильной группировкой, способ их получения (варианты), фармацевтические препараты на их основе и способ ингибирования секреции желудочной кислоты
DE69811735T DE69811735T2 (de) 1997-11-28 1998-11-18 Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
AU13565/99A AU752187C (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
KR1020007005804A KR20010032559A (ko) 1997-11-28 1998-11-18 위산 분비 억제용 헤테로고리 화합물, 그의 제조 방법 및그의 제약 조성물
BR9814755-2A BR9814755A (pt) 1997-11-28 1998-11-18 Composto, formulação farmacêutica, uso de um composto, e, processos para a preparação de um composto, para inibir a secreção do ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinais, e para o tratamento ou profilaxia de condições que envolvam infecção por helicobacter pylori da mucosa gástrica humana
EEP200000315A EE04060B1 (et) 1997-11-28 1998-11-18 Heterotsüklilised ühendid maohappesekretsiooni inhibeerimiseks, protsess nende valmistamiseks ja ravimkoostised
CZ20001947A CZ292349B6 (cs) 1997-11-28 1998-11-18 Heterocyklická sloučenina, způsoby její přípravy a použití a farmaceutická kompozice s jejím obsahem
SI9830381T SI1042324T1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
IL13614598A IL136145A0 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
IS5486A IS5486A (is) 1997-11-28 2000-05-10 Heterósýklísk efnasambönd til að hindra magasýruflæði, aðferðir við framleiðslu þeirra og lyfjablöndur er innihalda þau
NO20002721A NO315704B1 (no) 1997-11-28 2000-05-26 Heterocykliske forbindelser for inhibering av mavesyresekresjon, farmasöytiske preparater inneholdende slike forbindelser, fremgangsmåter forderes fremstilling, og deres anvendelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds

Publications (1)

Publication Number Publication Date
SE9704404D0 true SE9704404D0 (sv) 1997-11-28

Family

ID=20409181

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds

Country Status (32)

Country Link
US (1) US6518270B1 (https=)
EP (1) EP1042324B1 (https=)
JP (1) JP2001525322A (https=)
KR (1) KR20010032559A (https=)
CN (1) CN1142933C (https=)
AR (1) AR016972A1 (https=)
AT (1) ATE233263T1 (https=)
AU (1) AU752187C (https=)
BR (1) BR9814755A (https=)
CA (1) CA2311798A1 (https=)
CZ (1) CZ292349B6 (https=)
DE (1) DE69811735T2 (https=)
DK (1) DK1042324T3 (https=)
EE (1) EE04060B1 (https=)
ES (1) ES2191356T3 (https=)
HU (1) HUP0100601A3 (https=)
ID (1) ID24730A (https=)
IL (1) IL136145A0 (https=)
IS (1) IS5486A (https=)
MY (1) MY121032A (https=)
NO (1) NO315704B1 (https=)
NZ (1) NZ504355A (https=)
PL (1) PL340920A1 (https=)
PT (1) PT1042324E (https=)
RU (1) RU2241000C2 (https=)
SE (1) SE9704404D0 (https=)
SK (1) SK283904B6 (https=)
TR (1) TR200001530T2 (https=)
TW (1) TW515798B (https=)
UA (1) UA70932C2 (https=)
WO (1) WO1999028322A1 (https=)
ZA (1) ZA9810468B (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324093A (en) 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
HU230030B1 (hu) 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
EP1560584B1 (en) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab i inhibitors
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
KR20050008691A (ko) * 2002-04-19 2005-01-21 셀룰러 지노믹스 아이엔씨 이미다조[1,2-ａ]피라진-8-일 아민, 그의 제조방법 및사용방법
AU2003270489A1 (en) 2002-09-09 2004-03-29 Cellular Genomics, Inc. 6-ARYL-IMIDAZO(1,2-a)PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
WO2004029058A1 (ja) * 2002-09-25 2004-04-08 Sankyo Company, Limited 血中ガストリン濃度上昇の抑制のための医薬組成物
TW200418479A (en) * 2002-09-25 2004-10-01 Sankyo Co Pharmaceutical compositions for the treatment or prevention of visceral pains
EP1575951B1 (en) * 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
WO2004072080A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
US7405295B2 (en) 2003-06-04 2008-07-29 Cgi Pharmaceuticals, Inc. Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
WO2005005429A1 (en) 2003-06-30 2005-01-20 Cellular Genomics, Inc. Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
US7259164B2 (en) 2003-08-11 2007-08-21 Cgi Pharmaceuticals, Inc. Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
KR20060099524A (ko) 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
KR101764575B1 (ko) * 2004-07-28 2017-08-03 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-ｃ〕피리딘 화합물, 그 제조 방법 및 용도
CA2575345A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1h-pyrrolo[3,2-b]pyridines
ATE518858T1 (de) 2004-09-03 2011-08-15 Yuhan Corp Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür
CA2579083C (en) * 2004-09-03 2011-06-14 Yuhan Corporation Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof
CA2579127C (en) 2004-09-03 2011-08-02 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
WO2007024294A2 (en) 2005-05-03 2007-03-01 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
JP2009507032A (ja) 2005-09-02 2009-02-19 アボット・ラボラトリーズ 新規なイミダゾ系複素環
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
EP2029605A1 (en) * 2006-06-06 2009-03-04 Schering Corporation Imidazopyrazines as protein kinase inhibitors
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
WO2009102468A1 (en) 2008-02-13 2009-08-20 Cgi Pharmaceuticals, Inc. 6-aryl-imidaz0[l, 2-a] pyrazine derivatives, method of making, and method of use thereof
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
PE20120121A1 (es) 2008-12-08 2012-02-20 Gilead Connecticut Inc Derivados de imidazopirazina como inhibidores de syk
PL2716157T3 (pl) 2008-12-08 2017-06-30 Gilead Connecticut, Inc. Imidazopirazynowe inhibitory Syk
AU2011226689B2 (en) 2010-03-11 2016-09-01 Kronos Bio, Inc. Imidazopyridines Syk inhibitors
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
PE20160605A1 (es) 2013-07-30 2016-07-20 Gilead Connecticut Inc Formulaciones de inhibidores de la syk
KR101810798B1 (ko) 2013-07-30 2017-12-19 질레드 코네티컷 인코포레이티드 Ｓｙｋ 억제제의 다형체
KR20160090903A (ko) 2013-12-04 2016-08-01 길리애드 사이언시즈, 인코포레이티드 암을 치료하는 방법
GB201321738D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
TWI735853B (zh) 2013-12-23 2021-08-11 美商克洛諾斯生技有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
SG11201610551TA (en) 2014-07-14 2017-01-27 Gilead Sciences Inc Combinations for treating cancers
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
EP3672974A1 (en) 2017-08-25 2020-07-01 Gilead Sciences, Inc. Polymorphs of syk inhibitors
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
US11339168B2 (en) 2019-02-22 2022-05-24 Kronos Bio, Inc. Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507294A (en) * 1982-03-08 1985-03-26 Schering Corp. Imidazo[1,2-a]pyrazines
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
WO1991017164A1 (de) * 1990-04-27 1991-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue pyridazine
US5041442A (en) 1990-07-31 1991-08-20 Syntex (U.S.A.) Inc. Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
WO1992006979A1 (de) * 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
JPH07500329A (ja) * 1991-10-25 1995-01-12 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング ピロロ−ピリダジン
ATE229020T1 (de) * 1994-01-19 2002-12-15 Sankyo Co Pyrrolopyridazin-derivate
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds

Also Published As

Publication number Publication date
ATE233263T1 (de) 2003-03-15
WO1999028322A1 (en) 1999-06-10
AU1356599A (en) 1999-06-16
HUP0100601A2 (hu) 2001-09-28
MY121032A (en) 2005-12-30
NO315704B1 (no) 2003-10-13
PT1042324E (pt) 2003-06-30
NZ504355A (en) 2001-12-21
RU2241000C2 (ru) 2004-11-27
SK283904B6 (sk) 2004-04-06
ZA9810468B (en) 1999-05-21
ES2191356T3 (es) 2003-09-01
CZ20001947A3 (cs) 2000-11-15
AR016972A1 (es) 2001-08-01
CN1142933C (zh) 2004-03-24
NO20002721L (no) 2000-07-28
EE200000315A (et) 2001-10-15
CZ292349B6 (cs) 2003-09-17
UA70932C2 (uk) 2004-11-15
CN1284078A (zh) 2001-02-14
DK1042324T3 (da) 2003-05-05
BR9814755A (pt) 2000-10-03
EP1042324B1 (en) 2003-02-26
TW515798B (en) 2003-01-01
JP2001525322A (ja) 2001-12-11
NO20002721D0 (no) 2000-05-26
AU752187C (en) 2003-09-18
IS5486A (is) 2000-05-10
IL136145A0 (en) 2001-05-20
TR200001530T2 (tr) 2000-11-21
CA2311798A1 (en) 1999-06-10
ID24730A (id) 2000-08-03
SK6742000A3 (en) 2001-03-12
DE69811735T2 (de) 2003-12-18
US6518270B1 (en) 2003-02-11
HUP0100601A3 (en) 2002-10-28
PL340920A1 (en) 2001-03-12
EE04060B1 (et) 2003-06-16
EP1042324A1 (en) 2000-10-11
DE69811735D1 (de) 2003-04-03
KR20010032559A (ko) 2001-04-25
AU752187B2 (en) 2002-09-12
HK1030216A1 (en) 2001-04-27

Similar Documents

Publication Publication Date Title
SE9704404D0 (sv) New compounds
SE9700661D0 (sv) New compounds
SE9801526D0 (sv) New compounds
SE9602286D0 (sv) New compounds
SE9802794D0 (sv) New compounds
NZ510180A (en) Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors
FI970246A7 (fi) Dihydrobentsofuraanit
SE9401197D0 (sv) Active compounds
SE9802793D0 (sv) New compounds
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
SE0102808D0 (sv) New compounds
NO995289L (no) Benzimidazol-derivater
ATE196134T1 (de) Substituierte chinolinderivate, und ihre verwendung als inhibitoren der magensekretion
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
FR2631029B2 (fr) Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmacologiquement compatibles